Retraction: Molecular docking and in vivo/in vitro studies of a novel thiadiazole Schiff base as a hepatoprotective drug against angiogenesis induced by breast cancer.
- DOI
- 10.1039/d6ra90056a
- Published
- 2026 May 28
- Container
- RSC advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1039/d6ra90056a,
title = {Retraction: Molecular docking and in vivo/in vitro studies of a novel thiadiazole Schiff base as a hepatoprotective drug against angiogenesis induced by breast cancer.},
author = {Alqahtani NF and Alfaifi MY and Shati A A and Elbehairi SEI and Saleh AM and Kotb ES and Serag WM and Elshaarawy RFM and Alhamdi HW and Hassan YA},
year = {2026},
journal = {RSC advances},
doi = {10.1039/d6ra90056a},
url = {https://doi.org/10.1039/d6ra90056a}
}RIS
TY - JOUR TI - Retraction: Molecular docking and in vivo/in vitro studies of a novel thiadiazole Schiff base as a hepatoprotective drug against angiogenesis induced by breast cancer. AU - Alqahtani NF AU - Alfaifi MY AU - Shati A A AU - Elbehairi SEI AU - Saleh AM AU - Kotb ES AU - Serag WM AU - Elshaarawy RFM AU - Alhamdi HW AU - Hassan YA PY - 2026 JO - RSC advances DO - 10.1039/d6ra90056a UR - https://doi.org/10.1039/d6ra90056a ER -
APA
NF, A., MY, A., A, S. A., SEI, E., AM, S., ES, K., WM, S., RFM, E., HW, A., & YA, H. (2026). Retraction: Molecular docking and in vivo/in vitro studies of a novel thiadiazole Schiff base as a hepatoprotective drug against angiogenesis induced by breast cancer.. RSC advances. https://doi.org/10.1039/d6ra90056a
Source records
- pubmed · retrieved 2026-09-24T20:12:52.391Z